These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2121830

  • 1. Qualitative analysis of antibody binding. An in vitro assay for the evaluation and development of vaccines.
    Bruderer U, Fürer E, Cryz SJ, Lang AB.
    J Immunol Methods; 1990 Oct 19; 133(2):263-8. PubMed ID: 2121830
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Conjugate vaccines against Pseudomonas aeruginosa and malaria.
    Cryz SJ, Sadoff JC, Que JU.
    Contrib Microbiol Immunol; 1989 Oct 19; 10():166-89. PubMed ID: 2510972
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Properties determining the potential of naturally occurring and vaccine-induced human antibodies to protect against lethal infection of Pseudomonas aeruginosa.
    Bruderer U, Fürer E, Cryz SJ, Lang AB.
    Res Immunol; 1992 Feb 19; 143(2):165-74. PubMed ID: 1374194
    [Abstract] [Full Text] [Related]

  • 14. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T, Ito E, Nguyen VH, Haight M.
    Hum Vaccin Immunother; 2014 Feb 19; 10(10):2843-52. PubMed ID: 25483637
    [Abstract] [Full Text] [Related]

  • 15. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB, Glasier LM, Ellert NW, Cachia P, Kohn W, Lee KK, Paranchych W, Hodges RS, Irvin RT.
    Biomed Pept Proteins Nucleic Acids; 1995 Feb 19; 1(3):141-8. PubMed ID: 9346845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.
    Cryz SJ, Sadoff JC, Fürer E.
    Infect Immun; 1988 Jul 19; 56(7):1829-30. PubMed ID: 2454893
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.